Spironolactone Tablet, Film Coated
Product Images NDC 51655-153

NDC: 51655-153-26 Rev. A 0423, Spironolactone Tablets USP of 100mg strength is available in a bottle of 90 tablets. These are prescription-only tablets and must be stored at a controlled room temperature of 20° - 25°C (68° - 77°F) to protect them from light. The tablets contain 100mg of spironolactone, an aldosterone receptor antagonist, and a potassium-sparing diuretic. Keep this medicine out of the reach of children and store it in the original container. The medicine is repackaged by Northwind Pharmaceuticals from Zydus Pharmaceuticals (USA) Inc. The lot number is 0000000000 and the expiration date is 00/00/0000. Please refer to the package insert for dosage and other instructions.*

This is a table comparing the outcomes of patients taking Spironolactone (n=822) versus placebo (n=841) over a period of 42 months. The table shows that the difference in the outcomes between the two groups was statistically significant (log-rank p value < 0.001). However, no specific details on those outcomes are provided.*

This appears to be a table of subgroup data related to heart failure patients, including age range, sex, race, heart failure severity, and medication usage. There is also data related to laboratory values such as serum creatinine and potassium. The table includes information on the number of patients in each subgroup and their corresponding values for various metrics. Finally, there is a note on the efficacy of Spironolactone compared to placebo.*